Issue details

Access to End of Life medicines

During the COVID 19 situation there is an increased demand for access to End of Life medications. This paper highlights changes made and other changes needing to be made to meet the demand.

Decision type: Non-key

Decision status: Recommendations Approved

Notice of proposed decision first published: 20/04/2020

Decision due: 27 May 2020 by Executive Cabinet

Lead member: Executive Member for Adult Social Care and Population Health

Department: Commissioning

Agenda items

Documents

  • Access to End of Life medicines